C.R. Bard, Inc. company logo

# 1st Gen Model C.R. Bard, Inc. Surgical & medical instruments

$331.24 Last close price
at 28-dec-2017

BCR

Model's trade recommendations No return for period yet

$24.29B Market Cap

β 0.52  

BCR

Model (following trade recommendations)

BCR

Underlying stock

S&P 500

Index
Return for period
-1.40%
1.78%
52wk return
47.79%
16.82%
52wk Range
224.13—336.81
2000.54—2399.63
  • 0.78 (0.23%) Div (Yield)
  • HOLD Analysts consensus recommendation

C. R. Bard, Inc., together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, self-expanding and balloon-expandable covered stents, and vascular grafts; vena cava filters; biopsy devices; and a range of minimally invasive devices for the treatment of peripheral vascular and end-stage renal diseases. It also provides urology products, including Foley catheters to reduce the rate of urinary tract infections; fecal incontinence products; brachytherapy devices and radioactive seeds for the treatment of prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems etc.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Float 72M
P/E 28.77
Shares Outstanding 73M
% Held by Insiders 0.80%
% Held by Institutions 79.11%
EPS (last reported FY) $10.29
EPS (last reported Q) $3.02
EPS, estimated (last reported Q) $2.96
Total revenues $4 B
Net income $1 B